Nuwellis, Inc. (NUWE)

NASDAQ: NUWE · Real-Time Price · USD
0.9752
-0.0149 (-1.50%)
At close: Mar 28, 2025, 4:00 PM
0.9868
+0.0116 (1.19%)
After-hours: Mar 28, 2025, 7:42 PM EDT
-1.50%
Market Cap 4.27M
Revenue (ttm) 8.74M
Net Income (ttm) -10.62M
Shares Out 4.37M
EPS (ttm) -8.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 69,325
Open 0.9950
Previous Close 0.9901
Day's Range 0.9400 - 0.9900
52-Week Range 0.9000 - 14.3500
Beta 0.36
Analysts Strong Buy
Price Target 17.00 (+1,643.23%)
Earnings Date Mar 11, 2025

About NUWE

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Aus... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1999
Employees 38
Stock Exchange NASDAQ
Ticker Symbol NUWE
Full Company Profile

Financial Performance

In 2024, Nuwellis's revenue was $8.74 million, a decrease of -1.40% compared to the previous year's $8.86 million. Losses were -$10.62 million, -53.05% less than in 2023.

Financial Statements

Analyst Forecast

According to one analyst, the rating for NUWE stock is "Strong Buy" and the 12-month stock price forecast is $17.0.

Price Target
$17.0
(1,643.23% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Nuwellis, Inc. (NASDAQ:NUWE) Q4 2024 Earnings Conference Call March 11, 2025 9:00 AM ET Company Participants Vivian Cervantes - Gilmartin Group, Investor Relations John Erb - Interim President and Ch...

18 days ago - Seeking Alpha

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

MINNEAPOLIS, March 11, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company focused on transforming the lives of people with fluid overload, today reported...

19 days ago - GlobeNewsWire

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

John Erb, Current Chair of the Board, Appointed Interim President and CEO John Erb, Current Chair of the Board, Appointed Interim President and CEO

4 weeks ago - GlobeNewsWire

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

MINNEAPOLIS, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company focused on transforming the lives of people with fluid overload, today highlight...

5 weeks ago - GlobeNewsWire

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

MINNEAPOLIS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today annou...

5 weeks ago - GlobeNewsWire

Nuwellis Regains Compliance with Nasdaq Listing Requirements

MINNEAPOLIS, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (the “Company” or “Nuwellis”) today announced that the Company received formal written notice from The Nasdaq Stock Market ...

3 months ago - GlobeNewsWire

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nuwellis, Inc. (NASDAQ:NUWE) Q3 2024 Earnings Call Transcript November 11, 2024 9:00 AM ET Company Participants Vivian Cervantes - IR Nestor Jaramillo - President and CEO John Jefferies - CMO Rob Sco...

4 months ago - Seeking Alpha

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company focused on transforming the lives of people with fluid overload, today reported financial results...

4 months ago - GlobeNewsWire

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

MINNEAPOLIS, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company committed to transforming the lives of people with...

5 months ago - GlobeNewsWire

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Reimbursement rate to increase 397% per day effective January 1, 2025 New rate expected to encourage adoption of ultrafiltration therapy in the outpatient setting MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEW...

5 months ago - GlobeNewsWire

Nuwellis Announces Preliminary Results for Third Quarter of 2024

MINNEAPOLIS, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company dedicated to transforming the lives of patients suffering from fluid overload, today announced ce...

5 months ago - GlobeNewsWire

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

MINNEAPOLIS, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce t...

5 months ago - GlobeNewsWire

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

MINNEAPOLIS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will...

5 months ago - GlobeNewsWire

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

MINNEAPOLIS, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce ...

6 months ago - GlobeNewsWire

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

MINNEAPOLIS, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload...

7 months ago - GlobeNewsWire

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

Nuwellis, Inc. (NASDAQ:NUWE) Q2 2024 Earnings Conference Call August 13, 2024 9:00 AM ET Company Participants Vivian Cervantes - Gilmartin Group, Investor Relations Nestor Jaramillo - President, CEO ...

8 months ago - Seeking Alpha

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

MINNEAPOLIS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial res...

8 months ago - GlobeNewsWire

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE™ Therapy at Cincinnati Children's

MINNEAPOLIS, July 26, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, today announce...

8 months ago - GlobeNewsWire

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

MINNEAPOLIS, July 24, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload...

8 months ago - GlobeNewsWire

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will...

8 months ago - GlobeNewsWire

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children's

MINNEAPOLIS, July 17, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, is proud to an...

9 months ago - GlobeNewsWire

Nuwellis Announces Reverse Stock Split

MINNEAPOLIS, June 26, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload...

9 months ago - GlobeNewsWire

Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™

MINNEAPOLIS, June 25, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the recent g...

9 months ago - GlobeNewsWire

DaVita, Nuwellis Extend Pilot Collaboration for Aquadex

DaVita DVA recently extended the pilot phase of a previously announced supply and collaboration agreement with Nuwellis NUWE until Aug 31, 2024.At the conclusion of the pilot phase, DaVita may extend ...

Other symbols: DVA
10 months ago - Benzinga

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

Pilot Collaboration for Aquadex® Ultrafiltration Therapy for Adult Patients with Congestive Heart Failure is extended to August 31, 2024 Pilot Collaboration for Aquadex® Ultrafiltration Therapy for Ad...

10 months ago - GlobeNewsWire